Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity
Angelo Di Vincenzo,Marnie Granzotto,Marika Crescenzi,Camilla Costa,Stefano Piaserico,Vincenzo Vindigni,Roberto Vettor,Marco Rossato
DOI: https://doi.org/10.2147/DMSO.S405374
2023-06-23
Abstract:Angelo Di Vincenzo, 1 Marnie Granzotto, 1 Marika Crescenzi, 1 Camilla Costa, 1 Stefano Piaserico, 2 Vincenzo Vindigni, 3 Roberto Vettor, 1 Marco Rossato 1 1 Department of Medicine – DIMED, Clinica Medica 3, University - Hospital of Padova, Padova, Italy; 2 Department of Medicine - DIMED, Section of Dermatology, University - Hospital of Padova, Padova, Italy; 3 Department of Neurosciences, Clinic of Plastic Reconstructive and Aesthetic Surgery, University – Hospital of Padova, Padova, Italy Correspondence: Marco Rossato, Department of Medicine – DIMED, Clinica Medica 3, University Hospital of Padova, Via Giustiniani 2, Padova, 35128, Italy, Tel +39 49 8218746, Fax +39 49 8213332, Email Purpose: Psoriasis is a chronic systemic inflammatory disease involving the production of many pro-inflammatory cytokines derived from immune cells and interacting with different tissues leading to the typical skin lesions. Psoriasis shows a higher prevalence and a worse progression in obese than in lean subjects. The IL-23/IL-17 immune axis has a pivotal role in the pathogenesis of psoriasis and anti-IL-23 monoclonal antibodies are highly effective in its treatment. Since obesity in frequently associated with elevated insulin plasma levels, we have investigated the ability of in vitro differentiated human adipocytes to produce IL-23 at basal conditions and after insulin stimulation. Material and Methods: In vitro differentiated human adipocytes were incubated in the absence and presence of different insulin concentrations and the expression of IL-23 was analyzed by real-time PCR and Western blotting. Results: The results of this study show that in vitro differentiated human adipocytes spontaneously express IL-23 mRNA and protein being stimulated by insulin in a dose-dependent manner. The stimulatory effects of insulin on IL-23 expression were specific since it did not stimulate the expression of other well-known cytokines involved in psoriasis pathogenesis such as Il-22 nor LL-37. Furthermore, lipopolysaccharide did not stimulate IL-23 expression in human adipocytes, thus highlightening the specific effects of insulin in the stimulation of IL-23 expression in human adipocytes. Conclusion: Here we show that human adipocytes spontaneously express IL-23 and that insulin stimulates IL-23 production by these cells in a specific manner as other stimuli, known to be involved in psoriasis pathophysiology, are ineffective. These observations could explain the association between psoriasis and obesity, a condition frequently characterized by a state of insulin hypersecretion. Keywords: adipocyte, human, IL-23, insulin, obesity, psoriasis Psoriasis is a chronic systemic immune-mediated inflammatory disease with a prevalence of 1–3% worldwide. Although the etiology of this disease is still not precisely known, its pathogenesis, albeit incompletely, has been clarified and in particular the role of many pro-inflammatory cytokines derived from immune cells and interacting with different tissues leading to the typical lesions affecting the skin. The interleukin-23/interleukin-17 (IL-23/IL-17) immune axis is considered to have a pivotal role in the pathogenesis of psoriasis and in line with this, IL-17- and IL-23 are highly effective targets of psoriasis therapeutic strategies. 1 Psoriasis may be associated with several comorbidities such as psoriatic arthritis, mood disorders including depression, and a range of cardio-metabolic disorders that include myocardial infarction, hypertension, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). 2 In particular, a significant number of cross-sectional studies have shown that psoriasis is independently associated with obesity. 3–5 Recently, increasing evidence from prospective studies showed that obesity precedes psoriasis occurrence, with a clear dose–response association between body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR), and weight gain with psoriasis risk. 3 Accordingly, recent Mendelian randomization studies (based on genome-wide association) identified a causal link between obesity and psoriasis in European and Japanese populations, showing that genetically higher BMI increases the odds of psoriasis occurrence. 4,6 Several studies have also shown that weight loss in obese psoriatic patients improves psoriasis, with a linear dose–response association, with more weight loss being related to higher improvements in psoriasis severity. 2,5,7–9 Moreover, weight loss following lifestyle interventions such as diet and/or physical exercise may also prevent de novo psoriasis in obese sub -Abstract Truncated-
endocrinology & metabolism